Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00399"

Predicate	Value (sorted: default)
rdfs:label	"Zoledronate"
rdf:type	drugbank:drugs
drugbank:description	"Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronate is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis."
drugbank:drugCategory	drugcategory:Antihypocalcemic Agents drugcategory:Antiresorptives drugcategory:Bisphosphonates drugcategory:Bone Density Conservation Agents
owl:sameAs	drug:APRD01294 drug:Cholecalciferol drug:Zoledronate drug:Iron drug:Geranyl Diphosphate drug:Cholesterol drug:DB06286

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 5 triples

Context graph